Chinese english Germany Japanese Korea

TocilizuMab

TocilizuMab Struktur
375823-41-9
CAS-Nr.
375823-41-9
Englisch Name:
TocilizuMab
Synonyma:
Actemra;Atlizumab;R 1569;RoActemra;Actemra 200;TocilizuMab;Tocilizumab-Actemra;Tocilizumab,Atlizumab;anti-IL-6R Tocilizumab;Tocilizumab (anti-IL-6R)
CBNumber:
CB32735437
Summenformel:
C14H12O3
Molgewicht:
0
MOL-Datei:
Mol file
Request For Quotation

TocilizuMab Eigenschaften

storage temp. 
Store at -80°C
Löslichkeit
Soluble in DMSO
Aggregatzustand
Liquid
Farbe
Colorless to light yellow

Sicherheit

TocilizuMab Chemische Eigenschaften,Einsatz,Produktion Methoden

TocilizuMab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

TocilizuMab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 83)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou FandaChem Co.,Ltd. 		+8615858145714
 FandaChem@Gmail.com China 9206 55
Hebei Weibang Biotechnology Co., Ltd 		+8615531157085
 abby@weibangbio.com China 8810 58
Career Henan Chemica Co 		+86-0371-86658258 +8613203830695
 laboratory@coreychem.com China 30240 58
Shanghai Minbiotech Co., Ltd. 		+8617315815539
 sales@minbiotech.com CHINA 129 58
AFINE CHEMICALS LIMITED 		+86-0571-85134551
sales@afinechem.com China 15352 58
Wuhan Fortuna Chemical Co., Ltd 		+86-027-59207850
info@fortunachem.com China 5978 58
Hefei Hirisun Pharmatech Co., Ltd 		+8615056975894
 shawn@hirisunpharm.com CHINA 9911 58
Guangzhou TongYi biochemistry technology Co.,LTD 		+8613073028829
 mack@tongyon.com China 2994 58
Hebei Fengjia New Material Co., Ltd 		+86-0311-87836622 +86-17333973358
 sales06@hbduling.cn China 8053 58
TargetMol Chemicals Inc.
support@targetmol.com United States 38632 58
  • TocilizuMab
  • Actemra 200
  • R 1569
  • RoActemra
  • Tocilizumab,Atlizumab
  • anti-IL-6R Tocilizumab
  • Tocilizumab (anti-IL-6R)
  • Tocilizumab-Actemra
  • Actemra
  • Atlizumab
  • Research Grade Tocilizumab(DHC36902)
  • COVID-19,IL-6R,Anti-Human IL6R, Humanized Antibody,rheumatoid,respiratory failure,antibody,Interleukin Related,coronavirus disease,Tocilizumab,arthritis,inhibit,dyspnoea,Neutralizing,Inhibitor
  • 375823-41-9
  • API
Copyright 2019 © ChemicalBook. All rights reserved